secwatch.observer — SEC 8-K summary
======================================

Issuer:     NORTHWEST BIOTHERAPEUTICS INC (NWBO)
CIK:        0001072379
Form:       8-K
Filed at:   2024-03-14T23:59:59+00:00
Accession:  0001104659-24-034527
Event type: leadership
Sentiment:  neutral
Materiality: 0.25
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Director Jerry Jasinowski retires from Northwest Biotherapeutics Board at age 85
--------------------------------------------------------------------------------

- Jerry Jasinowski retired from Board on March 8, 2024, after more than a decade of service.
- Retirement due to health reasons, not due to any disagreement with company's operations.
- No replacement director named; board size decreases by one.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1072379/000110465924034527/0001104659-24-034527-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1072379/000110465924034527/tm248844d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-034527

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer